Related Experiment Video
Updated: May 23, 2026

Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze
Published on: October 29, 2019
Methamphetamine mimics the neurochemical profile of aging in rats and impairs recognition memory
Pedro Melo1, Ana Magalhães, Cecília J Alves
1IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal. pmelo@ibmc.up.pt
Abstract:
Brain neurochemistry and cognition performance are thought to decline with age. Accumulating data indicate that similar events occur after prolonged methamphetamine (MA) exposure. Using the rat as a model, the present study was designed to uncover common alteration patterns in brain neurochemistry and memory performance between aging and prolonged MA exposure. To this end, animals were treated with a chronic binge MA administration paradigm (20mg/kg/day from postnatal day 91 to 100). Three-age control groups received isovolumetric saline treatment and were tested at the MA age-matched period, and at 12 and 20 months. We observed that both MA and aged animals presented a long, but not short, time impairment in novelty preference and an increased anxiety-like behavior. Neurochemical analysis indicated similar MA- and age-related impairments in dopamine, serotonin and metabolites in the striatum, prefrontal cortex and hippocampus. Thus, the present data illustrate that MA may be used to mimic age-related effects on neurotransmitter systems and advocate MA treatment as a feasible animal model to study neuronal processes associated with aging.
Insights
Prolonged methamphetamine (MA) exposure in rats mimics age-related cognitive decline and neurochemical changes, particularly in dopamine and serotonin systems. This study suggests MA administration is a viable model for studying aging-related neuronal processes.
Area of Science:
- Neuroscience
- Gerontology
- Pharmacology
Background:
- Cognitive function and brain chemistry naturally decline with age.
- Prolonged methamphetamine (MA) exposure can induce similar neurochemical and cognitive deficits.
- Understanding these shared alterations is crucial for developing interventions for both aging and substance abuse.
Purpose of the Study:
- To investigate common patterns of brain neurochemistry and memory performance changes between aging and prolonged MA exposure in a rat model.
- To determine if MA administration can serve as a relevant model for studying age-related neuronal alterations.
- To compare behavioral and neurochemical outcomes in aged rats versus MA-treated rats.
Main Methods:
- Rats were administered a chronic binge methamphetamine (MA) paradigm (20mg/kg/day) during a specific developmental period.
- Control groups received saline and were tested at MA-matched ages, 12 months, and 20 months.
- Behavioral tests (novelty preference, anxiety-like behavior) and neurochemical analyses (dopamine, serotonin metabolites) were conducted.
Main Results:
- Both MA-exposed and aged rats exhibited long-term impairments in novelty preference and increased anxiety-like behavior.
- Neurochemical analyses revealed comparable MA- and age-related deficits in dopamine and serotonin metabolites across the striatum, prefrontal cortex, and hippocampus.
- Short-term memory was not significantly affected in either group.
Conclusions:
- Methamphetamine administration effectively models age-related changes in brain neurochemistry and cognitive function.
- The study validates MA treatment as a feasible animal model for investigating aging-associated neuronal processes.
- Findings highlight shared neurobiological pathways affected by aging and chronic MA exposure.
More Related Videos
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Pharmacodynamics in Geriatric Patients: Effects of Age
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...

